Objective: Pro-inflammatory cytokine-driven mechanisms have been implicated in vein graft failure, though little is known about the effect of hemodynamic factors and anti-inflammatory counter-regulatory mechanisms. We hypothesized that early temporal expression of the pro-inflammatory cytokine interleukin (IL)-1␤ and the anti-inflammatory cytokine IL-10 proceeds by way of wall shear stress-dependent pathways in the arterializing vein graft. Methods: Rabbits (n ‫؍‬ 27) underwent bilateral jugular vein carotid interposition grafts, and simultaneous unilateral distal carotid branch ligation, to produce both low-flow and high-flow grafts in the same animal. Vein grafts were harvested at 1, 3, 7, 14, and 28 days and were assessed for architecture, wall shear stress, and cytokine messenger RNA levels (quantitative real-time two-step reverse transcription polymerase chain reaction). Clinical Relevance: Neointimal hyperplasia continues to limit the durability of vein bypass grafts. Emerging evidence suggests that inflammatory mechanisms drive the neointimal hyperplasic response. This study demonstrates that specific hemodynamic forces (altered wall shear stress) differentially affect early pro-inflammatory interleukin (IL)-1␤ and delayed anti-inflammatory IL-10 signaling. These distinct temporal windows for IL-1␤ and IL-10 cytokine expression offer strategies for appropriately timed pro-inflammatory and anti-inflammatory therapies to interrupt pathologic vein graft adaptations.
Use of autologous vein bypass grafts is the most durable standard for revascularization procedures performed to treat occlusive cardiovascular diseases. In the United States it is estimated that 571,000 coronary artery bypass procedures 1 and approximately 125,000 lower extremity bypass procedures were performed in 1999. However, almost 20% of these vein bypass grafts will fail within a year, and 40% will fail by 5 years. 2, 3 Vein grafts undergo a defined sequence of adaptations after arterialization, though not all favor long-term patency. Although pathologic hallmarks of intimal hyperplasia have been well described, few substantial clinical interventions to prolong bypass graft patency have been found. Since many technical avenues for improved patency have been exhausted over recent decades, the future of improving the durability of these constructions lies primarily in better knowledge of and interventions based on the biologic features of the vein graft wall.
Inflammation is a pathologic feature of vein graft arterialization and failure, though it remains unclear whether the inflammation is primary or secondary. Pro-inflammatory cytokines tumor necrosis factor (TNF)-␣ and interleukin (IL)-1␤, have been associated with vein graft arterialization and intimal hyperplasia 4, 5 ; however, the initiating factors Supported by Grant NIH 1 K08 HL04070-01A1 from the National Instifor this inflammation and the temporal signaling roles of these inflammatory mediators in vein wall adaptations remain largely unknown. In addition, while both low and high wall shear environments induce arterial wall proinflammatory cytokines, [6] [7] [8] [9] the relationship between hemodynamics and vein graft cytokine signaling is not understood.
Thus we sought to determine the temporal expression of the pro-inflammatory cytokine IL-1␤ and the antiinflammatory cytokine IL-10 in response to specific early vein graft hemodynamic circumstances, that is, high and low wall shear stress. We hypothesized that the low wall shear stress hemodynamic setting, which exacerbates occlusive intimal hyperplasia, induces IL-1␤ expression, whereas high shear induces IL-10, and that both are time-dependent.
METHODS
Rabbit model of high and low wall shear vein grafts. This study was performed after securing appropriate institutional approval, and conforms with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publ No. 85-23, revised 1996). Twentyseven male New Zealand White rabbits (3.0-3.5 kg) underwent bilateral jugular vein interposition grafting followed by immediate unilateral distal carotid artery branch ligation, to create defined regions of differential vein graft wall shear. 10 Rabbits were premedicated with ketamine (30 mg/kg intramuscularly), endotracheal tubes were placed, and the animals were anesthetized with isoflurane. Intravenous heparin (1000 U) was administered, and bilateral external jugular veins and common carotid arteries were exposed through a vertical midline cervical incision. Vein bypass grafts were constructed with an anastomotic cuff technique, as described. 10 In brief, bilateral external jugular veins (3-cm long) were harvested. Polymer cuffs consisting of a 1-mm body loop were fashioned from a 4F endovascular catheter (Terumo Medical Corporation). Jugular vein ends were passed through a cuff, everted, and fixed with 8-0 silk suture. The carotid artery lumen was then exposed through a 2-cm arteriotomy, and the cuffed, reversed vein ends were inserted. A second 8-0 silk suture was used to secure the artery around the cuff. Finally, 1.0 cm of carotid artery back wall between the cuffs was cut away to permit vein graft extension.
Unilateral reduction in carotid artery, and thus vein graft, flow was accomplished with placement of 8-0 silk suture ligatures to completely occlude the internal carotid artery and three of the four primary branches of the external carotid artery. Mean blood flow rate through the arteries was recorded with an ultrasonic flow meter (2.0-mm probe; T106, Transonic Systems), both before and after ligation of the distal arterial branches. Animals (n ϭ 5 for each time point) were euthanized at 1, 3, 7, 14, and 28 days. Four normal, unmanipulated jugular veins were harvested from separate animals, and served as time zero baseline controls. Graft flow rates were recorded at harvest, again with use of the ultrasonic flow meter. High-resolution video images were obtained both at graft placement and harvest, and were used to determine external graft dimensions. Specimens were frozen in liquid nitrogen or immediately immersed in 10% neutral buffered formalin, avoiding the tissue within 2.0 mm adjacent to either cuff.
Morphologic analysis and hemodynamics. Morphologic analyses were completed with both in vivo external graft diameter and cross-sectional measurements (Axiovision v 3.1; Zeiss) on Masson and van Gieson elastinstained specimens. Digitized in vivo digital video and fixed microscopic cross-sectional images were collected and analyzed to determine lumen diameter (D V ) and neointimal cross-sectional area for each specimen. Wall shear stress was calculated from ϭ 32 Q/D V 3 , where Q is mean flow rate and is viscosity (0.03 poise).
Cytokine expression. Quantitative real-time twostep reverse transcription polymerase chain reaction (RT-PCR) was performed on paired vein grafts collected from all animals. Total RNA was isolated with TRI and BCP phase separation reagents according to the manufacturer's protocol (Molecular Research Center). After treatment with deoxyribonuclease I (Ambion), reverse transcription was completed with random hexamers (PE Applied Biosystem) to obtain a final complementary DNA concentration of 20 ng/L. TaqMan RT-PCR for IL-1␤ and IL-10 (Table) was performed on a PE 7700 Sequence Detection System, with use of 200 nmol/L forward primer, 200 nmol/L reverse primer, 50 nmol/L probe, and 10 ng cDNA per 25 L reaction volume (TaqMan Universal PCR Master Mix; PE Applied Biosystems). RT-PCR was run for 18S ribosomal RNA on all cDNA samples as an internal control. Samples were assayed in triplicate. The Comparative CT method 11 was used for experiments and data analysis. Results were expressed as relative IL-1␤ or IL-10 mRNA expression after normalization to 18S ribosomal RNA to minimize variability from RNA quality and RT efficiency, and finally were calibrated to unmanipulated jugular vein.
Immunohistochemical analysis. For IL-1␤ cytokine immunohistochemistry, tissues were fixed in 4% formalin, dehydrated, and embedded in paraffin, and 4-m thick sections were made. The slides were rehydrated, treated with microwave for 10 minutes, and endogenous peroxiCytokine primers and probes for quantitative real-time two-step polymerase chain reaction
Gene
Forward primer Reverse primer TaqMan probe   IL-1␤  TTGCTGAGCCAGCCTCTCTT  CTGGGTACCAAGGTTCTTTGAACT  CTGCCATTCAGGCAAGGCCAGC  IL-10  TGCGACAATGTCACCGATTT  TGCTGAAGGCGCTCTTCAC  ACTGCCTTGCTCTTGTTTTCACAGGG dase was blocked with 0.3% hydrogen peroxide in methanol. Sections were washed with Tris-buffered saline solution (TBS) and blocked with 10% normal rabbit serum for 1 hour at room temperature. Staining for IL-1␤ was carried out with affinity purified goat anti-rabbit IL-1␤ immunoglobulin G (IgG) as a primary antibody (5 g/mL in TBS-1% bovine serum albumin for 2 hours at 37°C). Preimmune goat IgG was used as control, as was unmanipulated vein. 12 After washing with TBS-Tween 20 (0.1%), the slides were incubated with rabbit anti-goat IgG conjugated to horseradish peroxidase-labeled dextran polymer (EnVision Plus Peroxidase; Dako Cytomation) for 30 minutes at room temperature. After washing, the reaction was developed with diaminobenzidine (Sigma). Counterstaining was performed with hematoxylin.
Statistical analysis. The role of time and wall shear was described statistically with two-way repeated measures analysis of variance, Wilcoxon signed rank test, and paired t tests. When possible, pairwise analyses were performed. Multiple comparisons were completed with the StudentNewman-Keuls method (Sigma Stat; SSPS).
RESULTS
Rabbit model of high and low wall shear vein grafts. The surgical, physiologic, and biomechanical outcomes of this model have been described. 10 Significant surgical morbidity and mortality were zero. In brief, distal branch ligation resulted in an immediate 90% flow reduction (P Ͻ .001) in the vein graft on the ligated side and 36% flow augmentation (P ϭ .01) in the contralateral vein graft. Associated with this flow perturbation was an approximate 15-fold differential flow rate detected in vein grafts throughout the 28-day observation period. The shear force differed 15-fold initially between low-flow and high-flow vein grafts. While no significant alteration in shear stress was detectable in low-flow grafts over time, a late 68% decrease (P ϭ .039) of shear stress occurred by day 28 in high-flow vein grafts, owing to outward vein wall remodeling.
Morphologic features. As detailed previously, 10 neointimal hyperplasia was first noted at day 3 in both low-flow 
Fig 2.
Relative messenger RNA expression calibrated to normal vein. Results are expressed as relative interleukin-1␤ or interleukin-10 mRNA expression after normalization to 18S ribosomal RNA, to minimize variability from RNA quality and RT efficiency, and finally calibrated to unmanipulated jugular vein. With arterialization, vein wall interleukin-1␤ exhibits rapid induction that is higher in the low shear stress setting. On the other hand, interleukin-10 exhibits relatively delayed upregulation, most notably by high wall shear stress at 14 days. and high-flow wall shear grafts. Rapid development of hyperplasia was observed in low-flow shear grafts between day 7 (42.4 Ϯ 14.5 m) and day 14 (181.4 Ϯ 31.1 m), averaging 230.6 Ϯ 35.4 m by day 28. In the high-flow shear grafts, however, marked reduction in neointimal hyperplasia (P Ͻ .001) was seen, with intimal thickness approximately one sixth that in low-flow grafts at day 28 (36.1 Ϯ 17.6 m; Fig 1) . Serial sections from the proximal, middle, and distal portions of perfusion-fixed vein grafts showed no consistent variation in extent of intimal thickening.
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Cytokine expression quantitation. RT-PCR for IL-1␤ and IL-10 revealed several shear and time-dependent cytokine expression signatures (Fig 2) . Time after vein graft arterialization was a statistically significant overall determinant of expression for both cytokines (P Ͻ .001 for each).
IL-1␤ was induced 1188-fold in low shear vein grafts and 366-fold in high shear vein grafts by the first postarterialization day. This elevation was followed by a rapid reduction toward baseline by the third day. Flow significantly affected IL-1␤ expression (P Ͻ .001), though the differential was greatest at 1 day (P ϭ .002) and 3 days (P Ͻ .001).
On the other hand, vein graft arterialization more slowly and modestly induced IL-10 mRNA expression. Overall, this occurred independent of shear (P ϭ .152), though there was a statistically significant higher expression for high shear grafts at 14 days (P Ͻ .001).
Immunohistochemical analysis. IL-1␤ stained intensely, and localized to the developing neointima at days 1 and 3 (Fig 3) . IL-10 studies were not performed, because of lack of appropriate anti-rabbit IL-10 antibodies.
DISCUSSION
Vein grafts undergo a defined sequence of adaptations after arterialization, though not all favor long-term patency. Their failure mechanisms seem to generally mirror the occlusive disease seen in arteries. If the hemodynamic environment that led to this adaptation of the vein graft wall is removed and the vein is placed back into the venous system, the structure of the vein wall reverts toward its original architecture. 4 This strongly implicates hemodynamic factors as the determinant of vein graft adaptations.
Research during the 1980s and 1990s yielded important new knowledge regarding the mechanisms of vein graft failure. Early work focused on mechanical factors. [13] [14] [15] [16] Intimal hyperplasia has been noted to occur at vein graft areas of low flow, 13 probably areas of low wall shear stress. 14, 15 Progress has been made in deciphering the biochemical mediators of the cellular events induced by these hemodynamic forces, [17] [18] [19] and the rabbit vein graft model facilitated much of this research. [19] [20] [21] More recent work has specifically examined the role of inflammatory mediators in vein graft failure. 4, 5, [22] [23] [24] With use of previous technologies, perturbations in cytokine and growth factor levels have been associated with vein graft arterialization, 4, 22, 25 but specific cause-and-effect links between hemodynamic factors, inflammatory biochemical mediators, and vein wall adaptations are still lacking.
Since these initial studies, more powerful molecular techniques and enhanced therapeutic approaches have been developed. It is in this setting that we sought to build on this previous work, to more precisely define the temporal expression of prototypical cytokines IL-1␤ and IL-10 in response to specific early vein graft hemodynamic circumstances (high and low wall shear stress). Our results reveal striking time-dependent perturbations and shear modulation of mRNA expression patterns for these cytokines.
In our previously described model, low shear grafts develop robust intimal hyperplasia. 10 In contrast, high shear triggers mechanisms that appear to protect against occlusive adaptations. Thus we examined vein grafts in these differential flow environments (relatively labeled low and high shear) in the same animal, which enabled more powerful statistical analysis. Vein grafts are exposed to the continuum of shear stresses clinically. There is no defined "normal" shear for human vein grafts, though our model captures clinically relevant ranges from 2 to 20 dynes/cm 2 . Directed attention across this spectrum enables us to systematically link shear stress forces with specific cytokine signaling pathways.
Experimental studies have documented direct evidence of IL-1␤ participation in the modulation of arterial intimal growth, and lack of biologically active IL-1␤ abrogates arterial intimal hyperplasia. 7 Locally chronic delivery of IL-1␤ to coronary adventitia induced neointima formation, and this effect is abolished by simultaneous treatment with neutralizing antibody to IL-1␤. 26 In vitro studies demonstrate that IL-1␤ holds many properties that suggest its involvement in vein graft failure. It induces adhesion molecule expression, 27 alters endothelial cell surface in a manner that favors coagulation and thrombosis, acts as a chemoattractant to monocytes and macrophages, and stimulates smooth muscle cell migration and proliferation. 28 Experiments performed on the balloon-injured porcine coronary artery demonstrated very early and short (first 3 days) IL-1␤ mRNA expression in injured artery. 29 Under the condition of our experiments, most IL-1␤ produced locally in the arterializing vein graft occurs in the first few days, and this matches the protein-based determinations of others, 5 as well as the arterial wall response. 29 IL-1␤ protein localized to the developing neointima at early time points, which confirmed the expression data. With such a narrow early time window, there is potential for enormous effect from a properly timed short course of anti-IL-1␤ therapy to minimize longer term vein graft occlusive adaptations. Such an approach might be accomplished with drugs already available for clinical use, such as anakinra. 30 Consistent with the theory that pro-inflammatory cytokine mechanisms drive downstream vein graft adaptations, this early quantitative IL-1␤ mRNA level change is temporally distinct from the time course of later morphologic and cellular changes in the vein graft wall. High pro-inflammatory cytokine levels, as in the low flow setting, correlated positively with greater intimal hyperplasia.
As opposed to IL-1␤, induction of IL-10 by vein graft arterialization occurred slowly, reaching a peak 2 weeks later. The significantly higher IL-10 levels induced by the high shear setting, which also protected against occlusive wall changes, supports a protective effect for IL-10. Early administration of IL-10 may provide a useful strategy for early inflammation suppression. 31 Our findings provide new direct in vivo evidence for IL-10 signaling in vein graft arterialization.
There are limitations to our study that prevent broader conclusions. While we probably accurately interrogated the mRNA expression in these whole tissues, limited information is provided regarding actual active protein levels and exact localization, especially for IL-10, because we were unable to confirm the mRNA expression due to lack of appropriate antibodies. Thus it must be acknowledged that there could be post-transcriptional regulation or other disconnects between transcription and translation that may affect the final active protein levels in this system. Cytokine receptor dynamics may also serve as an important control point for modulation of these inflammatory processes.
Understanding the molecular mechanisms of vein graft failure will suggest clinical interventions that will alter the natural history of the process. The early IL-1␤-mediated and IL-10 -mediated processes serve as a potential early site for therapeutically interrupting pathologic vein graft adaptations to arterialization. [32] [33] [34] [35] The dramatic differences in neointimal burden between high and low shear stress grafts in this model suggest that modest perturbations in cytokine activities may substantially affect early vein graft remodeling.
